AI Echocardiographic Screening of Cardiac Amyloidosis
AI Echocardiographic Screening of Cardiac Amyloidosis
Enrolling by invitation · NCT06664866 · Registry updated 2026-07-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| AI Echocardiographic Screening of Cardiac Amyloidosis | Amyloid Neuropathies, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Nutritional and Metabolic Diseases, amyloidosis, familial amyloid neuropathy, hereditary amyloidosis, hereditary disease, inborn errors of metabolism, inherited neurodegenerative disorder, metabolic disease, nervous system disorder, neurodegenerative disease, neuromuscular disease, peripheral nervous system disorder, proteostasis deficiencies | Enrolling by invitation | Not applicable | 2026-07-22 | NCT06664866 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Cedars-Sinai Medical Center | 161 |
| Northwestern Medicine | 8 |
| Palo Alto Veteran Affairs Hospital | 1 |
| Providence Heart & Vascular Institute | 1 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cedars Sinai Medical Center | Los Angeles | United States | 1 |
| Northwestern Medicine | Chicago | United States | 1 |
| Palo Alto Veteran Affairs Hospital | Palo Alto | United States | 1 |
| Providence Heart and Vascular Institute | Portland | United States | 4 |